1
Consolidated Financial Highlights
First Nine Months of the Fiscal Year Ending
May 31, 2009 (FY5/09 3Q)
- Supplementary Information -
INTER ACTION Corporation
April 10, 2009

Copyright © 2009 INTER ACTION Corporation
2
Financial Results (FY5/09 3Q)
(yen in millions)
FY5/08 3Q
FY5/09 3Q
YoY change
(%)
Amount
%
Amount
%
Sales
1,189
100.0%
657
100.0%
(44.7)%
Gross profit
464
39.0%
229
34.9%
(50.4)%
Operating income
(211)
(17.8)%
(240)
(36.5)%
-
Ordinary income
(262)
(22.1)%
(278)
(42.3)%
-
Net income
(197)
(16.6)%
(189)
(28.8)%
-
Sales
Lower sales due to weak demand from global economic downturn
SG&A expenses
Tight cost controls, mainly for personnel, sales promotion and R&D expenses. Cut down on SG&A
expenses 205 million yen year-on-year.
Operating income
Efforts to reduce SG&A expenses failed to fully offset the decreased sales. Loss increased 28
million yen year-on-year.
Ordinary income
Improvement in foreign exchange loss (FY5/08 3Q: -32 million yen
FY5/09 3Q: -25 million yen)
Net income
Includes gain of 30 million yen from sale of manufacturing rights resulting from sale to Teseda
Corporation of non-exclusive rights to manufacture DFT (design-for-test) test system hardware
Factors affecting performance

Copyright © 2009 INTER ACTION Corporation
3
Comparison of Sales by Product
(yen in millions)
FY5/08 3Q
FY5/09 3Q
Amount
Amount
Electronics testing
equipment
976
610
Illuminators
905
472
Image testing
equipment
16
89
Tester equipment
54
48
Security systems
213
47
Total
1,189
657
76%
1%
5%
18%
Illuminators
Image testing equipment
Tester equipment
Security
71%
14%
7%
8%
FY5/08 3Q
FY5/09 3Q
Down 44.7%
Addition of
solar cell-
related
sales

Copyright © 2009 INTER ACTION Corporation
4
R&D Expenses/Capital Expenditures/
Depreciation and Amortization
(yen in millions)
FY5/08
FY5/09
3Q
Full year
3Q
R&D expenses
91
102
24
Capital expenditures
59
89
29
Depreciation and
amortization
79
113
83
Development of
new illuminators
and other activities
Mainly for purchase
of manufacturing
equipment and
software

Copyright © 2009 INTER ACTION Corporation
5
Consolidated Balance Sheets
(yen in millions)
FY5/08
FY5/09 3Q
Change
Assets
Cash and deposits in banks
1,944
1,127
(817)
Trade notes and accounts
receivable
293
182
(110)
Raw materials
316
308
(7)
Work in process
316
248
(67)
Total current assets
3,096
2,117
(979)
Total fixed assets
994
1,154
159
Total assets
4,091
3,271
(819)
Liabilities
Trade accounts payable
94
6
(87)
Short-term borrowings
25
4
(20)
Total current liabilities
863
886
22
Corporate bonds
550
170
(380)
Long-term borrowings
638
378
(259)
Total long-term liabilities
1,194
554
(640)
Total liabilities
2,058
1,440
(617)
Net assets
Common stock
1,102
1,102
-
Capital surplus
1,033
1,033
-
Retained earnings
337
147
(189)
Treasury stock
(435)
(448)
13
Total shareholders’ equity
2,038
1,835
(203)
Total net assets
2,033
1,831
(202)
Total liabilities and net assets
4,091
3,271
(819)
Decrease in
trade payables
Repayment of long-
term borrowings
Booking of net loss
Redemption of
corporate bonds
Payment for
term deposits